Neoadjuvant Erlotinib Treatment in Patients with Resectable Non-Small Cell Lung Carcinoma

被引：0
|
作者：
Van Gool, Matthijs [1 ]
Kiomp, Houke [1 ]
机构：
[1] NKI AVL, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
neoadjuvant; Surgery; EGFR-TKI;
D O I：
10.1016/j.jtho.2016.11.834
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.05-049
引用
收藏
页码：S644 / S645
页数：2
相关论文
共 50 条
  • [41] Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series
    Hu, Yan
    Ren, Siying
    Yang, Lulu
    Tong, Zhongyi
    Wang, Ruoyao
    Han, Wei
    Zeng, Chao
    Li, Jina
    Xiao, Peng
    Wang, Li
    Yu, Fenglei
    Liu, Wenliang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [42] Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Xu, Feng
    Hui, Zhenzhen
    Zhao, Gang
    Liu, Jie
    Zhang, Huan
    Zeng, Ziqing
    Zhang, Ran
    Provencio, Mariano
    Ren, Xiubao
    You, Jian
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (05) : 2193 - +
  • [43] Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer
    Conroy, Michael R.
    Dennehy, Colum
    Forde, Patrick M.
    LUNG CANCER, 2023, 183
  • [44] Neoadjuvant atezolizumab plus chemotherapy in resectable non-small cell lung cancer (NSCLC).
    Shu, Catherine A.
    Grigg, Claud
    Chiuzan, Codruta
    Garofano, Robert F.
    Patel, Vijeta
    Hernandez, Susana
    Negri, Tiffany
    Sacher, Adrian G.
    Smith-Marrone, Stephanie
    Stoopler, Mark
    Gainor, Justin F.
    Awad, Mark M.
    D'Ovidio, Frank
    Sonett, Joshua R.
    Bacchetta, Matthew
    Saqi, Anjali
    Rizvi, Naiyer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] Role of Neoadjuvant Immune Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer
    Riano, Ivy
    Abuali, Inas
    Sharma, Aditya
    Durant, Jewelia
    Dragnev, Konstantin H. H.
    PHARMACEUTICALS, 2023, 16 (02)
  • [46] Neoadjuvant immunochemotherapy of pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
    Chen, Y.
    Yan, B.
    You, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S108 - S109
  • [47] Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers
    Wu, Xinyu
    Chau, Yi Fung
    Bai, Hua
    Zhuang, Xiaofei
    Wang, Jie
    Duan, Jianchun
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [48] Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer
    Hu, Yan
    Ren, Si-Ying
    Wang, Ruo-Yao
    Zeng, Chao
    Li, Ji-Na
    Xiao, Peng
    Wu, Fang
    Yu, Feng-Lei
    Liu, Wen-Liang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] Somatic mutation variant analysis in rural, resectable non-small cell lung carcinoma patients
    Mitchem, Jonathan B.
    Miller, Amanda
    Manjunath, Yariswamy
    Barbirou, Mouadh
    Raju, Murugesan
    Shen, Yuanyuan
    Li, Guangfu
    Avella, Diego M.
    Chaudhuri, Aadel A.
    Shyu, Chi-Ren
    Warren, Wesley C.
    Tonellato, Peter J.
    Kaifi, Jussuf T.
    CANCER GENETICS, 2022, 268 : 75 - 82
  • [50] Erlotinib for first line treatment in unselected patients (p) with advanced or metastatic non-small cell lung carcinoma (NSCLC)
    Jimenez, U.
    Gurpide, A.
    Isla, D.
    Garcia-Campelo, R.
    Firvida, J.
    Vinolas, N.
    Jaen, A.
    Montalar, J.
    Regueiro, P.
    Massuti, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345